IDBI Capital Market Pages

Score Board

Particulars

Company Name

Ajanta Pharma Ltd

Year End

202603

Full Year

Equity (र)Cr.

24.99

B.V.Rs

338.00

Sales (र)Cr.

4,845.92

NP Rs Cr.

941.57

NP Var%

4.00

Div%

1,400.00

CPS (र)

88.90

EPS Rs

75.40

Traded Value (र)Lakhs

100.55

52 Week High

3,506.00

52 Week Low

2,335.00

Price BSE

3,417.00

Price NSE

3,419.00

Market Capital(Rs Cr.)

42,688.00

P/C Ratio

38.40

P/E Ratio

45.30

Price Vs.BV

10.11

Latest Quarter

Year End

202603

Sales Rs Cr.

1,210.53

NP (र)Cr.

197.28

NP Var %

2.00

Trailing Twelve Months

Year End

202603

Sales

4,217.54

OPM

-2.92

853.85

NP Var%

3.92

EPS

75.36

45.34

Filing complaints on SCORES - Easy & quick

Register on Scores portal - https://scores.sebi.gov.in/
Mandatory details for filing complaints on SCORES
1. Name, PAN, Address, Mobile Number, Email ID
Benefits:
1. Effective communication
2. Speedy redressal of the grievances
Please refer https://scores.sebi.gov.in/ for more information.

Welcome To IDBI Direct

IDBI CAPITAL MARKETS & SECURITIES LTD. (IDBI Capital), a wholly owned subsidiary of IDBI Bank Ltd., is a fully integrated financial services provider catering to the needs of retail, institutional and corporate clients. Incorporated in December 1993, today it has a net-worth of around INR 3 billion and employs over 200 employees in 17 branches, spread over 17 cities across India. The Retail Broking & Distribution division of IDBI Capital offers online trading in Equities, F&O, Mutual Funds and IPOs, through the investing portal, www.idbidirect.in. We also distribute various Third Party Products, like Fixed Income Products, Mutual Funds, etc. We are amongst the top 10 MF distributors in India.

SEBI Regn. Nos.: NSE (CM, F&O, CD) -INZ000007237 | BSE (CM, F&O) - INZ000007237 | IDBI Capital Markets & Securities Limited is AMFI Registered Mutual Fund distributor our AMFI Regn No. ARN 0893 valid till January 20, 2028 | NSDL DP ID: IN300079 | NSE Member Code - 07066 | BSE Clg. No - 84 | For Complaints & Grievances Mail to : redressal@idbicapital.com

IDBI CAPITAL MARKETS & SECURITIES LTD. 6th Floor, IDBI Tower, World Trade Center, Cuffe Parade, Mumbai 400 005, India.

Tel: (+022) 022 40691700 | Email - info@idbidirect.in

"IDBI Capital is distributor for Mutual Funds and IPOs"
"Investment in securities market are subject to market risks, read all the related documents carefully before investing."

Reporting of Cyber Incidents
Helpline Number – 18002003388/022- 022-3913 5001 – Option (3) Dedicated Email Id – cyberalert@idbicapital.com

BSE Code:	532331	NSE Symbol:	AJANTPHARM	P/E(TTM):	45.34
ISIN Demat:	INE031B01049	Div & Yield %:	0.82	EPS(TTM):	75.36
Book Value (Rs ):	338.0498657	Market Cap (Rs Cr.):	42688	Face Value(Rs):	2